Chronic obstructive pulmonary disease is a condition of persistent, progressive lung destruction caused by inhalation of damaging particles. Many current treatments are expensive, come with side-effects, or have very little effect on some patients.

Kurtis’s research aims to address this problem by investigating a new source of possible treatments for COPD – the microbiome. His work uses high fibre diets, supplements, or probiotic “good” bacteria to improve the microbiome’s ability to produce beneficial short-chain fatty acids – potentially of providing a safe, cheap and readily available method to help patients to prevent or treat COPD.


Kurtis Budden

Project type 
Year of funding